Abstract
Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERβ has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemical detection of ERβ in archival breast tumours. © 2001 Cancer Research Campaignhttp://www.bjcancer.com
Keywords: ERβ, breast cancer, immunohistochemistry, formalin-fixed, paraffin-embedded material
Full Text
The Full Text of this article is available as a PDF (413.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allred D. C., Harvey J. M., Berardo M., Clark G. M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155–168. [PubMed] [Google Scholar]
- Dotzlaw H., Leygue E., Watson P. H., Murphy L. C. Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res. 1999 Feb 1;59(3):529–532. [PubMed] [Google Scholar]
- Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
- Harvey J. M., Clark G. M., Osborne C. K., Allred D. C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999 May;17(5):1474–1481. doi: 10.1200/JCO.1999.17.5.1474. [DOI] [PubMed] [Google Scholar]
- Järvinen T. A., Pelto-Huikko M., Holli K., Isola J. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol. 2000 Jan;156(1):29–35. doi: 10.1016/s0002-9440(10)64702-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuiper G. G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5925–5930. doi: 10.1073/pnas.93.12.5925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leygue E., Dotzlaw H., Watson P. H., Murphy L. C. Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res. 1998 Aug 1;58(15):3197–3201. [PubMed] [Google Scholar]
- Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996 Aug 19;392(1):49–53. doi: 10.1016/0014-5793(96)00782-x. [DOI] [PubMed] [Google Scholar]
- Paech K., Webb P., Kuiper G. G., Nilsson S., Gustafsson J., Kushner P. J., Scanlan T. S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997 Sep 5;277(5331):1508–1510. doi: 10.1126/science.277.5331.1508. [DOI] [PubMed] [Google Scholar]
- Speirs V., Adams I. P., Walton D. S., Atkin S. L. Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland. J Clin Endocrinol Metab. 2000 Apr;85(4):1601–1605. doi: 10.1210/jcem.85.4.6493. [DOI] [PubMed] [Google Scholar]
- Speirs V., Malone C., Walton D. S., Kerin M. J., Atkin S. L. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res. 1999 Nov 1;59(21):5421–5424. [PubMed] [Google Scholar]
- Speirs V., Parkes A. T., Kerin M. J., Walton D. S., Carleton P. J., Fox J. N., Atkin S. L. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res. 1999 Feb 1;59(3):525–528. [PubMed] [Google Scholar]
- Taylor A. H., Al-Azzawi F. Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol. 2000 Feb;24(1):145–155. doi: 10.1677/jme.0.0240145. [DOI] [PubMed] [Google Scholar]